Investigating how portal vein thrombosis affects liver transplantation outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the correlation between portal vein thrombosis (PVT) and the prognosis of liver transplantation. Participants will be divided into two groups: those with PVT and those without, allowing for comparative analysis of their data. The study will estimate the prevalence and risk factors associated with PVT, develop a predictive model for clinical use, and assess the prognostic impact of PVT on liver transplantation outcomes. Data will be collected from various medical imaging, surgical procedures, and follow-up treatments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Liver transplantation recipients
2. Aged 18 years or older.

Exclusion Criteria:

1. Retransplantation
2. Multi-organ transplantation
3. Portal vein tumor thrombus

Where it's running

• Beijing Friendship Hospital, Capital Medical University
  Beijing, China Recruiting

Study contacts

• Study coordinator: Ru-zhou Cai, M.D.
• Email: 18722563616@126.com
• Phone: 18722563616

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis

  This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.

  Recruiting Phase 4 Asian Institute Of Medical Sciences · Hyderābād, Sindh · NCT07521332

• Factors that affect reopening of blocked portal veins in people with cirrhosis and gastroesophageal varices

  This project looks at past records and follow-up to see which factors are linked with reopening (recanalization) of blocked portal veins in people who have cirrhosis and endoscopy-confirmed gastroesophageal varices.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07473375

• Apixaban for portal vein clots that appear more than a year after laparoscopic splenectomy

  This trial tests whether taking apixaban twice daily can treat portal vein blood clots that develop more than a year after laparoscopic splenectomy in people with cirrhosis.

  Recruiting Northern Jiangsu People's Hospital · Yangzhou, Jiangsu · NCT07461545

• Apixaban for portal vein thrombosis occurring more than one year after laparoscopic splenectomy and azygoportal disconnection

  This trial will try whether taking apixaban 2.5 mg twice daily can treat portal vein clots that appear more than a year after laparoscopic splenectomy and azygoportal disconnection in people with cirrhosis.

  Recruiting Northern Jiangsu People's Hospital · Yangzhou, Jiangsu · NCT07461532

• Comparing blood thinners for people with cirrhosis and portal vein clots

  This will try enoxaparin, warfarin, or apixaban in people with cirrhosis and portal vein thrombosis (with or without liver cancer) to see which controls the clot and is safest.

  Recruiting Phase 4 Mansoura University · Al Mansurah, Dakahlia Governorate · NCT07132515

• Registry for patients undergoing TIPS implantation for portal hypertension

  This study is collecting information from patients with serious portal hypertension who are getting a TIPS procedure to see how well it works and what complications might happen afterward.

  Recruiting University Hospital Freiburg · Freiburg im Breisgau · NCT05782556

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.